Abstract
In this report we aim to present our experience with primary immunodeficiency patients included in the National Rare Disease Program registry and consulted at the Allergy and Immunology Department of the „Professor Doctor Octavian Fodor” Regional Institute of Gastroenterology and Hepatology during the Coronavirus disease 2019 (COVID-19) pandemic, as well as to review the current understanding of COVID-19 immunopathology followed by possible protective mechanisms against the severe infection in these highly susceptible individuals.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
